The RLS Radiopharmacy Network
Bringing Innovation to Molecular Imaging

Our Focus and Vision

A leading radiopharmacy network partner.

Substantial investment in rapid expansion to be the leading radiopharmacy network providing predictive and diagnostic molecular imaging products, services and related therapeutic products.

Our Priorities

  • $2 Billion investment in the future of molecular imaging within the next 10 years.

  • $500M Investment in our existing radiopharmacy network to enhance our PET capability.

  • Doubling the size of our radiopharmacy network to 60 SPECT and PET pharmacies by 2023.

  • Investing in our product portfolio to bring your patients innovative diagnostic and therapeutic products.

  • Strengthening the supply chain through multi-sourcing to ensure patients are treated with unparalleled products when needed.

  • GE Channel Partner.

Our Network

Our network is growing:
  • We are committed to doubling the size of our network by 2023.
  • We are adding new technologies to our existing network and expanding our capabilities to provide new and unique PET products to all existing operations.
  • We will continue to bring high quality products and services to new markets.
  • We are expanding our services with mobile imaging and outpatient clinics to meet the growing needs of your patients and population.
Quality and consistency you can trust
  • Our pharmacies set the gold-standard for standard operating procedures across all sites.
  • We are adding new technologies to our existing network and expanding our capabilities to provide new and unique PET products to all existing operations.
  • Our clean rooms are designed and built using our industry leading specifications.
  • All sites are equipped with the most technically qualified equipment in the industry.
  • Real-Time tracking of your order from preparation to delivery ensures the right product at the right time for the right patient
  • Standardized delivery vehicles.
  • Highly trained personnel.

99.9%

99.99991% - Confirmed accuracy rate for approximately three million doses dispensed annually (2)


>99%

>99% Product delivery record, regardless of weather conditions (rain, sleet, snow, or hail)


<1%

<1% Customer product complaint rate


20+

Over 20 patient procedures per minute performed with RLS supplied products (4)

Reliability that supports high departmental
performance.

Full-service pharmacies located in key geographic areas.

Network of reliable, full service radiopharmacies located in key geographic areas*

*All services provided within a 100 mile radius of each pharmacy





  • Innovative leukocyte-locking system

Our robust chain of custody and unique secure lock system includes multiple steps of verification throughout the pickup and delivery of the WBC specimen. This means that the specific patient-labeled sample is returned for administration to the patient identified on the label.
  • Ensures sample integrity through the entire process from sample collection to patient injection
  • Secure lock system ensures only you can access your patient’s sample
  • Chain of custody maintained throughout the transport and labeling process

Quality and Compliance

Setting the standard to provide excellence

  • RLS is the only nationwide radiopharmacy network to have achieved The Joint Commission Gold Seal of Approval
  • RLS only compounds and dispenses FDA-approved radiopharmaceutical products, a key step in ensuring patient safety
  • Highly trained staff – RLS has a team of experienced Nuclear Pharmacists and Radiation Safety Officers available to support you and your staff
  • Fully equipped and aligned to USP<825> standards
  • Enhanced procedures for COVID-19 – we have enhanced our procedures to keep your patients, staff and our team safe while continuing to provide high quality products and services